These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Effect of smoking on diabetes mellitus and dyslipidemia (effect of smoking on glucose and lipid metabolism)]. Saito K; Sone H Nihon Rinsho; 2013 Mar; 71(3):443-8. PubMed ID: 23631232 [TBL] [Abstract][Full Text] [Related]
9. Bibliography. Hyperlipidaemia and cardiovascular disease. Current world literature. Curr Opin Lipidol; 2012 Aug; 23(4):386-91. PubMed ID: 22801387 [No Abstract] [Full Text] [Related]
10. [The program of lowering of residual vascular risk (The Residual Vascular Risk Reduction Initiative). Part II. Methods of correction]. Zubareva MIu; Susekov AV Kardiologiia; 2010; 50(9):64-70. PubMed ID: 21118169 [No Abstract] [Full Text] [Related]
11. MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment. Quiat D; Olson EN J Clin Invest; 2013 Jan; 123(1):11-8. PubMed ID: 23281405 [TBL] [Abstract][Full Text] [Related]
12. Lipid metabolism in chronic kidney disease: the role of statins in cardiovascular risk. Wanner C; Drechsler C; Krane V J Ren Nutr; 2007 Jan; 17(1):75-8. PubMed ID: 17198938 [TBL] [Abstract][Full Text] [Related]
13. [Effects of garlic allicor tablets on lipid metabolism and risk of fatal cardiovascular complications in patients with atherogenic dyslipoproteinemia]. Gromnatskiĭ NI; Sereditskaia ZhE; Lazareva NV; Sereditskiĭ AV; Annenkova GV Vopr Pitan; 2007; 76(6):60-4. PubMed ID: 18219944 [TBL] [Abstract][Full Text] [Related]
14. Cardiovascular effects of alcohol, cocaine, and acquired immune deficiency. Brown J; King A; Francis CK Cardiovasc Clin; 1991; 21(3):341-76. PubMed ID: 2044115 [No Abstract] [Full Text] [Related]
15. Is the risk for cardiovascular disease increased in all phenotypes of the polycystic ovary syndrome? Daskalopoulos GN; Karkanaki A; Karagiannis A; Mikhailidis DP; Athyros VG Angiology; 2011 May; 62(4):285-90. PubMed ID: 21474465 [TBL] [Abstract][Full Text] [Related]
19. Health-coaching strategies to improve patient-centered outcomes. Butterworth S J Am Osteopath Assoc; 2010 Apr; 110(4 Suppl 5):eS12-4. PubMed ID: 20430916 [No Abstract] [Full Text] [Related]
20. Type 2 diabetes, dyslipidemia, and vascular risk: rationale and evidence for correcting the lipid imbalance. Carmena R Am Heart J; 2005 Nov; 150(5):859-70. PubMed ID: 16290951 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]